跳至主要内容
临床试验/NCT04160325
NCT04160325招募中不适用

The Effect of the Exclusive Enteral Nutrition Combined With Azathioprine in Maintaining Remission of Patients With Crohn's Diseases After Surgery

Zhu Weiming1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
54
试验地点
1
主要终点
the 1 year postoperative anastomotic recurrence

研究概览

简要总结

for some patients with Crohn's diseases undergoing surgery,whether exclusive enteral nutrition(EEN) could delay the disease relapse needs exploration.The trial will study whether the efficacy of postoperative EEN could help keeping remission.

详细描述

For patients with Crohn's disease(CD), whether exclusive enteral nutrition(EEN) following bowel resection and anastomosis could delay the disease recurrence remains unkown. In this study, CD patients after surgery will be divided into two groups: one group is treated with 3 months' EEN and then turn to normal diet after 3 months; the other group is given with normal diet all through. All patients will be adminstrated with oral azathioprine after surgery. Then, the rates of 1 year postoperative endoscopic recurrence will be compared between groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CD patients who undergoing bowel resection with anastomosis

排除标准

  • patients who had administered with immunomodulators or biological agents patients who were created stoma

研究组 & 干预措施

3 months exclusive enteral nutrition plus azathioprine

Experimental

patients underwent surgery in this arm will given 3 months exclusive enteral nutrition,and free diet after 3 months. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.

干预措施: postoperative 3-month exclusive enteral nutrition (Dietary Supplement)

3 months exclusive enteral nutrition plus azathioprine

Experimental

patients underwent surgery in this arm will given 3 months exclusive enteral nutrition,and free diet after 3 months. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.

干预措施: azathioprine (Drug)

normal diet plus azathioprine

Active Comparator

patients underwent surgery in this arm will given free diet all through. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.

干预措施: azathioprine (Drug)

normal diet plus azathioprine

Active Comparator

patients underwent surgery in this arm will given free diet all through. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.

干预措施: normal diet (Other)

结局指标

主要结局

the 1 year postoperative anastomotic recurrence

时间窗: 1 year

the 1 year postoperative anastomotic recurrence

次要结局

未报告次要终点

研究者

发起方
Zhu Weiming
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhu Weiming

Director, Head of General Surgery, Principal Investigator, Clinical Professor

Jinling Hospital, China

研究点 (1)

Loading locations...

相似试验